You are here: Industry Insights > LabCorp

News List

Labcorp COVID-19 PCR Test Home Collection Kit Receives FDA Emergency Authorization for Ages 2-17 americanpharmaceuticalreview
May 17, 2021
Labcorp has announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Pixel by Labcorp COVID-19 PCR Test Home Collection Kit for ages 2-17.
FDA Authorizes Test for People without Known, Suspected COVID-19 Infection americanpharmaceuticalreview
July 31, 2020
The U.S. Food and Drug Administration (FDA) reissued the LabCorp COVID-19 RT-PCR Test emergency use authorization (EUA) to include two new indications for use ...
LabCorp Launches New COVID-19 Clinical Trial Site contractpharma
June 02, 2020
To connect patients with US research trials; streamlining recruitment into studies to speed research.
Labcorp Accelerates Adoption of Decentralized Clinical Trials contractpharma
June 01, 2020
LabCorp’s drug development business, Covance, is expanding its technology ecosystem to accelerate the adoption of decentralized clinical trials, often referred to as hybrid and virtual clinical trials.
FDA Authorizes First COVID-19 At-Home Test americanpharmaceuticalreview
April 24, 2020
The U.S. Food and Drug Administration (FDA) has authorized the first diagnostic test with a home collection option for COVID-19.
LabCorp, Ciox Health Partner to Create COVID-19 Patient Data Registry contractpharma
April 14, 2020
Groundbreaking registry aims to help researchers accelerate COVID-19 diagnosis, treatment and prevention strategies.
zPREDICTA Enters Collaboration with LabCorp contractpharma
March 04, 2020
Agreement advances use of 3D cell cultures in research and drug development.
Covance Unveils New R&D Center in Shanghai contractpharma
September 19, 2019
LabCorp’s Covance Drug Development business celebrated the opening of its new R&D Center in Shanghai, China, which is now its largest facility in the Asia Pacific region.
Covance Launches Lab Solution within FSPx Offering contractpharma
August 30, 2019
Program comprises a clinical analytics service and clinical operations capabilities.
Labcorp, QIAGEN announce companion diagnostic for metastatic breast cancer biospectrumasia
June 11, 2019
Piqray, in combination with fulvestrant, and therascreen PIK3CA PCR mutation analysis assay received approval from the U.S. Food and Drug Administration (FDA) on May 24, 2019.

Previous page 1 2 Next page